US Stock MarketDetailed Quotes

MGNX Macrogenics

Watchlist
  • 2.560
  • +0.100+4.07%
Close Feb 14 16:00 ET
  • 2.560
  • 0.0000.00%
Post 20:01 ET
160.67MMarket Cap-1.63P/E (TTM)

About Macrogenics Company

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Company Profile

SymbolMGNX
Company NameMacrogenics
Listing DateOct 10, 2013
Issue Price16.00
Founded2000
CEODr. Scott Koenig, M.D.,PhD
MarketNASDAQ
Employees339
Fiscal Year Ends12-31
Address9704 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850-3368
Phone1-301-251-5172
Websitehttp://www.macrogenics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Scott Koenig, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 3.71M
  • Eric Risser
  • Chief Operating Officer
  • --
  • Dr. Stephen L. Eck
  • Senior Vice President, Clinical Development and Chief Medical Officer
  • 1.75M
  • Dr. Ezio Bonvini, M.D.
  • Senior Vice President, Research and Chief Scientific Officer
  • --
  • James Karrels
  • Senior Vice President, Chief Financial Officer and Corporate Secretary
  • 1.58M
  • Beth Smith
  • Vice President, Controller, Treasurer and Principal Accounting Officer
  • --
  • Jeffrey Stuart Peters
  • Senior Vice President, General Counsel and Corporate Compliance Officer
  • --
  • Thomas Spitznagel
  • Senior Vice President, Technical Operations
  • --
  • William K. Heiden
  • Chairman of the Board
  • 180.13K
  • Meenu Chhabra Karson
  • Independent Director
  • 335.41K
  • Edward M. Hurwitz, J.D.
  • Independent Director
  • 147.63K
  • Dr. Margaret A. Liu, M.D.
  • Independent Director
  • 318.32K
  • Dr. David C. Stump,M.D.
  • Independent Director
  • 160.75K
  • Dr. Jay Siegel, M.D.
  • Independent Director
  • 167.21K
  • Federica O'Brien
  • Independent Director
  • 152.00K
  • Dr. Karen Jean Ferrante, M.D.
  • Independent Director
  • 135.75K
  • Scott T. Jackson, M.B.A.
  • Independent Director
  • 167.63K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!